US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2463 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
PR953, Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
FDA901, FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
BRC961, Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores

Newly added tissue microarrays in recent month:

2016-08-23 HPan-Ade180Sur-02, Pancreatic cancer tissue array, 90 cases of carcinoma and matched normal adjacent tissue (NAT, 1 core/case), with survival data
2016-08-22 LY241c, Lymph node and tonsil tissue array, 12 cases/ 24 cores, replacing LY241b
2016-08-22 PA242c, Pancreas cancer tissue array with adjacent normal pancreas tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing PA242b
2016-08-22 BR10010e, Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing BR10010d
2016-08-22 ST2091a, Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases/208 cores, replacing ST2091
2016-08-22 CA941, Cardia cancer tissue array, including TNM, clinical stage and pathology grade, 94 cases/94 cores
2016-08-16 HCol-Ade180Sur-08, Colon cancer tissue array 90 cases of tumor and matched normal adjacent tissue, respectively (1 core/case)
2016-08-16 HLiv-HCC180Sur-05, Hepatocellular carcinoma tissue array, 95 cases. Tumor and normal adjacent tissue.
2016-08-15 HPan-A150CS-02, Pancreatic ductal adenocarcinoma, 78 cases. Tumor and matched NAT (normal adjacent tissue)
2016-08-11 FCO405a, Frozen colon cancer tissue array with matched cancer adjacent tissue, including TNM, clinical stage and pathology grade, 20 cases/40 cores, replacing FCO405
2016-08-09 FDA808h, Multiple organ cancer tissue array with cancer adjacent tissue as contral (2 slide set), including TNM, clinical stage and pathology grade, 72 cases/ 72 cores, replacing FDA808g
2016-08-04 T383, Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 2 serial sections, 6 cases/24 cores
2016-08-03 T385b, Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T385a
2016-08-01 BR804b, Breast cancer tissue array with matched cancer adjacent breast tissue, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing BR804a
2016-07-25 CO953, Colon cancer tissue array with matched normal adjacent and matched or unmatched metastatic carcinoma tissue, with TNM, clinical stage and survival data, 39 cases/95 cores, replacing CO952a
2016-07-25 T056a, Colon cancer with normal colon tissue array,including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T056
2016-07-25 T175b, Brain tumor tissue array with brain tissue, including pathology grade, 12 cases/24 cores, replacing T175a
2016-07-25 LY1001c, Diffuse large-B cell lymphoma tissue array, 100 cases/100 cores, replacing LY1001b
2016-07-18 CR501a, Cervix cancer tissue array with cancer adjacent tissue, including TNM, clinical stage and pathology grade, 50 cases/50 cores, replacing CR501
2016-07-18 LC706a, Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 75 cases/75 cores, replacing LC706